Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.
J Am Chem Soc
; 140(43): 14440-14454, 2018 10 31.
Article
in En
| MEDLINE
| ID: mdl-30272974
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Melanoma, Experimental
/
Toll-Like Receptor 1
/
Toll-Like Receptor 2
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
J Am Chem Soc
Year:
2018
Document type:
Article